Literature DB >> 15685555

La protein is a potent regulator of replication of hepatitis C virus in patients with chronic hepatitis C through internal ribosomal entry site-directed translation.

Masao Honda1, Takeo Shimazaki, Shuichi Kaneko.   

Abstract

BACKGROUND AND AIMS: Translation of hepatitis C virus is an essential step of viral replication and is mediated by an internal ribosome entry site. We previously reported that the hepatitis C virus internal ribosome entry site is most active during the synthetic (S) or mitotic (M) phases and lowest during quiescent (G 0 ) phase. Here, we investigated host factors responsible for the regulation of the hepatitis C virus internal ribosome entry site.
METHODS: We synchronized the cell-cycle progression and evaluated gene-expression dynamics of host factors and kinetics of hepatitis C virus internal ribosome entry site activity in cells at various points during the cell cycle by using a complementary DNA microarray. We also validated the significance of identified host factors on hepatitis C virus replication in vivo.
RESULTS: Hepatitis C virus internal ribosome entry site activity correlated with a gene cluster induced in the S and G 2 /M phases. It is interesting to note that most initiation factors known to bind or interact with the hepatitis C virus internal ribosome entry site [poly(rC)-binding protein 2, polypyrimidine tract binding protein, eukaryotic initiation factor 3, eukaryotic initiation factor 2gamma, eukaryotic initiation factor 2beta, La protein, and heterogenous nuclear ribonucleoprotein L] were induced during the S and G 2 /M phases. Expression of La protein, polypyrimidine tract binding protein, and eukaryotic initiation factor 3 (p116, p170) were predominantly repressed in G 0 phase and induced in S and G 2 /M phases. Suppression or overexpression of La protein and polypyrimidine tract binding protein in RCF-26 significantly changed hepatitis C virus internal ribosome entry site activity. In the livers of patients with chronic hepatitis C, expression of La protein was significantly increased and correlated with the amount of hepatitis C virus RNA.
CONCLUSIONS: Hepatitis C virus uses host factors induced during cell division but not during quiescence for replication. Of these, La protein is a potent regulator and enhances hepatitis C virus replication in regenerating hepatocytes in patients with chronic hepatitis C.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15685555     DOI: 10.1053/j.gastro.2004.11.064

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  8 in total

1.  DHX15 Is a Coreceptor for RLR Signaling That Promotes Antiviral Defense Against RNA Virus Infection.

Authors:  Sowmya Pattabhi; Megan L Knoll; Michael Gale; Yueh-Ming Loo
Journal:  J Interferon Cytokine Res       Date:  2019-05-15       Impact factor: 2.607

2.  Dissecting the interferon-induced inhibition of hepatitis C virus replication by using a novel host cell line.

Authors:  Marc P Windisch; Michael Frese; Artur Kaul; Martin Trippler; Volker Lohmann; Ralf Bartenschlager
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

Review 3.  Oral manifestations of hepatitis C virus infection.

Authors:  Marco Carrozzo; Kara Scally
Journal:  World J Gastroenterol       Date:  2014-06-28       Impact factor: 5.742

4.  How hepatitis C virus modifies the immunological profile of Sjögren syndrome: analysis of 783 patients.

Authors:  Pilar Brito-Zerón; Hoda Gheitasi; Soledad Retamozo; Albert Bové; María Londoño; Jose-Maria Sánchez-Tapias; Miguel Caballero; Belchin Kostov; Xavier Forns; Srini V Kaveri; Manuel Ramos-Casals
Journal:  Arthritis Res Ther       Date:  2015-09-10       Impact factor: 5.156

5.  Efficient Suppression of Hepatitis C Virus Replication by Combination Treatment with miR-122 Antagonism and Direct-acting Antivirals in Cell Culture Systems.

Authors:  Fanwei Liu; Tetsuro Shimakami; Kazuhisa Murai; Takayoshi Shirasaki; Masaya Funaki; Masao Honda; Seishi Murakami; Minkyung Yi; Hong Tang; Shuichi Kaneko
Journal:  Sci Rep       Date:  2016-08-03       Impact factor: 4.379

6.  Peretinoin, an acyclic retinoid, inhibits hepatocarcinogenesis by suppressing sphingosine kinase 1 expression in vitro and in vivo.

Authors:  Masaya Funaki; Juria Kitabayashi; Tetsuro Shimakami; Naoto Nagata; Yuriko Sakai; Kai Takegoshi; Hikari Okada; Kazuhisa Murai; Takayoshi Shirasaki; Takeru Oyama; Taro Yamashita; Tsuguhito Ota; Yoh Takuwa; Masao Honda; Shuichi Kaneko
Journal:  Sci Rep       Date:  2017-12-05       Impact factor: 4.379

7.  Refractoriness of hepatitis C virus internal ribosome entry site to processing by Dicer in vivo.

Authors:  Dominique L Ouellet; Isabelle Plante; Vincent Boissonneault; Cherifa Ayari; Patrick Provost
Journal:  J Negat Results Biomed       Date:  2009-08-13

8.  The acyclic retinoid Peretinoin inhibits hepatitis C virus replication and infectious virus release in vitro.

Authors:  Tetsuro Shimakami; Masao Honda; Takayoshi Shirasaki; Riuta Takabatake; Fanwei Liu; Kazuhisa Murai; Takayuki Shiomoto; Masaya Funaki; Daisuke Yamane; Seishi Murakami; Stanley M Lemon; Shuichi Kaneko
Journal:  Sci Rep       Date:  2014-04-15       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.